Medical Republic
group backed by medicinal cannabis industry players is attempting to shut down proposals from the AMA and Pharmacy Guild of Australia to immediately suspend all Category 5 products containing THC concentrations above 98%.
The Cannabis Council of Australia represents organisations like Montu, which boasts a portfolio including Alternaleaf telehealth clinic, Leafio distribution, uMeds fulfilment and Saged clinical education, not to mention Montu-branded cannabis products.
Non-Montu members of the council include various pharmaceutical products wholesalers, pharmacies, dispensaries and distributors.
In direct response the letter sent to Health Minister Mark Butler earlier in the week by the AMA and the guild urging action on the medicinal cannabis industry, the CCA has released a statement of its own.
“Both the Council and the AMA have identified gaps in oversight, but prohibition is not the solution,” CCA CEO Lisa Penlington said.
Ms Penlington took particular issue with the AMA and guild’s call for immediate suspension of products containing THC concentrations in excess of 98%.
The AMA and guild not only made this recommendation together as part of the letter to Mr Butler, but also included it in their respective submissions to the TGA’s review of the safety and regulatory oversight of unapproved medicinal cannabis products.
